Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CHMP recommends AstraZeneca’s Tezspire for approval to treat severe asthma
Image: AstraZeneca’s Tezspire has been recommended as an add-on therapy in patients aged 12 years and above with severe asthma. Credit: Ulrike Mai from Pixabay.
Image: AstraZeneca’s Tezspire has been recommended as an add-on therapy in patients aged 12 years and above with severe asthma. Credit: Ulrike Mai from Pixabay.